Related Experiment Videos
Response of alveolar macrophages to amiodarone and desethylamiodarone, in vitro
1Department of Pharmacology and Toxicology, West Virginia University Health Sciences Center, Morgantown 26506.
Abstract:
Administration of the antiarrhythmic drug amiodarone to humans or animals may result in lung damage. Amiodarone is metabolized to desethylamiodarone and other minor metabolites. Because amiodarone and the metabolites accumulate in the lungs, it is not possible to ascertain the role of each of these compounds in the induction of toxicity. In the present study, we utilized primary cell cultures of rat alveolar macrophages to study the actions of amiodarone and desethylamiodarone individually and in combination. Neither drug species was metabolized by the cells over 42 h in culture thereby permitting assessment of the actions of each. Both drugs induced the formation of lamellar inclusions, indicative of the development of cellular phospholipidosis. Desethylamiodarone appeared to induce formation of the structures in a shorter period of time than did amiodarone, although given adequate exposure, the two drugs produced similar responses. At shorter times of exposure and lower concentrations, desethylamiodarone was more cytotoxic than amiodarone as assessed by the release of lactate dehydrogenase. The two in combination resulted in cytotoxicity that was more than additive. The results of this study indicate that in vitro cultures of alveolar macrophages may be quite useful in studying the role these cells play in the pulmonary toxicity associated with amiodarone therapy. Additionally, this study supports the idea that a significant portion of the toxicity may result from the actions of desethylamiodarone.
Insights
Amiodarone lung toxicity may stem from its metabolite, desethylamiodarone. This study shows desethylamiodarone causes phospholipidosis and more cytotoxicity in rat alveolar macrophages than amiodarone alone or combined.
Area of Science:
- Pharmacology
- Toxicology
- Cell Biology
Background:
- Amiodarone, an antiarrhythmic drug, can cause lung damage.
- Amiodarone is metabolized into desethylamiodarone and other compounds.
- Both amiodarone and its metabolites accumulate in the lungs, complicating toxicity studies.
Purpose of the Study:
- To investigate the individual and combined effects of amiodarone and desethylamiodarone on rat alveolar macrophages.
- To determine the role of desethylamiodarone in amiodarone-induced pulmonary toxicity.
Main Methods:
- Primary cultures of rat alveolar macrophages were used.
- Cells were exposed to amiodarone and desethylamiodarone individually and in combination.
- Cytotoxicity was assessed by lactate dehydrogenase release.
- Cellular phospholipidosis was evaluated by the formation of lamellar inclusions.
Main Results:
- Neither amiodarone nor desethylamiodarone were metabolized by the macrophages.
- Both drugs induced lamellar inclusions, indicating phospholipidosis.
- Desethylamiodarone induced phospholipidosis faster than amiodarone.
- Desethylamiodarone was more cytotoxic than amiodarone at lower concentrations and shorter exposure times.
- Combined exposure resulted in more than additive cytotoxicity.
Conclusions:
- In vitro alveolar macrophage cultures are useful for studying amiodarone pulmonary toxicity.
- Desethylamiodarone contributes significantly to amiodarone-induced lung toxicity.